PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.76%
Some net income increase while MRVL is negative at -29.15%. John Neff would see a short-term edge over the struggling competitor.
-8.42%
Both reduce yoy D&A, with MRVL at -0.84%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
202.00%
Lower deferred tax growth vs. MRVL's 158250.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-12.12%
Negative yoy SBC while MRVL is 10.70%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
51.38%
Slight usage while MRVL is negative at -79.54%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
776.60%
AR growth while MRVL is negative at -51.87%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-29.82%
Negative yoy inventory while MRVL is 28.64%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
104.17%
AP growth well above MRVL's 14.05%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-85.61%
Both reduce yoy usage, with MRVL at -1617.21%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-1175.00%
Negative yoy while MRVL is 71.84%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
1.49%
Some CFO growth while MRVL is negative at -20.15%. John Neff would note a short-term liquidity lead over the competitor.
-17.99%
Negative yoy CapEx while MRVL is 25.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
17.99%
Less M&A spending yoy vs. MRVL's 5184.62%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-129.63%
Negative yoy purchasing while MRVL stands at 23.30%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-55.41%
We reduce yoy sales while MRVL is 20.68%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
56.06%
Growth well above MRVL's 94.37%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-273.52%
We reduce yoy invests while MRVL stands at 57.66%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-33.33%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
214.29%
Issuance growth of 214.29% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
20.63%
Buyback growth below 50% of MRVL's 52.32%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.